News
European drug regulators classify NAION as a 'very rare' side effect of semaglutide — the active ingredient in Ozempic, Wegovy. The risk often emerged after two years of use ...
Novo Nordisk has plummeted back to Earth after a stunning rise driven by Ozempic and Wegovy. Can the storied Danish pharma ...
Overweight patients waiting for operations could safely use a particular type of weight-loss treatment to reduce the risk of ...
Overweight patients waiting for operations could safely use a particular type of weight-loss treatment to reduce the risk of ...
One popular health platforms is promoting GLP-1 microdosing for weight loss: But how safe and effective is this approach?
Texas AG sues Eli Lilly for bribery related to prescribing GLP-1 meds for weight loss and diabetes, alleging unethical inducements to medical providers.
Cardiology is undergoing a year of rapid change, driven by innovations that are expanding diagnostic capabilities, advancing treatment options and personalizing care. From artificial intelligence and ...
Texas Attorney General Ken Paxton is accusing Eli Lilly and Co. of a kickback scheme to induce medical providers to prescribe ...
Texas Attorney General Ken Paxton on Tuesday sued U.S. drugmaker Eli Lilly for allegedly “bribing” providers to prescribe its ...
The FDA said it's taking action to protect patients from unapproved animal-derived thyroid medications and expressed concern over the use of unapproved GLP-1 receptor agonists for weight loss, such as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results